AEON Net Income Per Share from 2010 to 2025
| AEON Stock | 1.08 0.06 5.88% |
Net Income Per Share | First Reported 2010-12-31 | Previous Quarter 77.73535742 | Current Value 73.32 | Quarterly Volatility 457.07109666 |
Check AEON Biopharma, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AEON Biopharma,'s main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 0.0 or Depreciation And Amortization of 92.2 K, as well as many indicators such as Price To Sales Ratio of 37.85, Dividend Yield of 0.0 or Days Sales Outstanding of 23.22. AEON financial statements analysis is a perfect complement when working with AEON Biopharma, Valuation or Volatility modules.
AEON | Net Income Per Share | Build AI portfolio with AEON Stock |
Pair Trading with AEON Biopharma,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AEON Biopharma, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AEON Biopharma, will appreciate offsetting losses from the drop in the long position's value.Moving against AEON Stock
| 0.5 | CMB | Cambium Bio | PairCorr |
| 0.4 | DWTX | Dogwood Therapeutics, | PairCorr |
| 0.37 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.35 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.34 | DSGN | Design Therapeutics | PairCorr |
The ability to find closely correlated positions to AEON Biopharma, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AEON Biopharma, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AEON Biopharma, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AEON Biopharma, to buy it.
The correlation of AEON Biopharma, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AEON Biopharma, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AEON Biopharma, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AEON Biopharma, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of AEON Biopharma, Correlation against competitors. To learn how to invest in AEON Stock, please use our How to Invest in AEON Biopharma, guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AEON Biopharma,. If investors know AEON will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AEON Biopharma, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of AEON Biopharma, is measured differently than its book value, which is the value of AEON that is recorded on the company's balance sheet. Investors also form their own opinion of AEON Biopharma,'s value that differs from its market value or its book value, called intrinsic value, which is AEON Biopharma,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AEON Biopharma,'s market value can be influenced by many factors that don't directly affect AEON Biopharma,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AEON Biopharma,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if AEON Biopharma, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AEON Biopharma,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.